Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

1.43
BATS BZX Real-Time Price
As of 1:11pm ET
 +0.10 / +7.52%
Today’s Change
0.84
Today|||52-Week Range
8.46
-43.92%
Year-to-Date

Today’s Trading

Previous close1.33
Today’s open1.34
Day’s range1.33 - 1.55
Volume4,042,753
Average volume (3 months)2,089,810
Market cap$97.0M
Dividend yield--
Data as of 12:58pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)-15.15%
Earnings growth (this year)+31.20%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.93%
P/E ratioNM
Price/Sales27.35
Price/Book6.37

Competitors

 Today’s
change
Today’s
% change
CNATConatus Pharmaceutic...+0.03+0.61%
XOMAXOMA Corp-0.01-1.35%
MNOVMediciNova Inc-0.25-6.46%
ZSANZosano Pharma Corp-0.26-3.23%
Data as of 1:12pm ET, 07/30/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$5.7M
Annual profit (last year)-$43.0M
Net profit margin-749.95%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts